Search
Refine your search
936 results found
Baker & Hostetler LLP | USA | 13 Feb 2020
FDA Turns Its Attention to Celebrity Influencers
New studies to explore the power of endorsement and disclosure techniques
Bristows | USA, European Union | 7 Feb 2020
Transatlantic echoes: FTC and FDA focus on competition in biologics
For those who don’t make a practice of reading press releases from the US regulatory bodies, a recent joint statement by the US Food & Drug
McDermott Will & Emery | USA | 4 Feb 2020
Anticompetitive Conduct in Biologics - An Enforcement Priority with FTC and FDA
Today the Federal Trade Commission (FTC) and the Food and Drug Administration (FDA) released joint guidance concerning competition for biologics
Hogan Lovells | USA | 29 Jan 2020
FDA may accept DMFs for electronics and software components of drug-led combination products
On Monday, the FDA published the draft guidance, “Type V DMFs for CDER-Led Combination Products Using Device Constituent Parts With Electronics or
McDermott Will & Emery | USA | 29 Jan 2020
Inherent Claim Limitation Necessarily Present in the Prior Art Invalidates Patent
Addressing the issue of obviousness, the US Court of Appeals for the Federal Circuit affirmed the district court’s finding that a patent was invalid
McDermott Will & Emery | USA | 28 Jan 2020
Available Now - 2019 Digital Health Year in Review
Throughout the past year, the healthcare and life science industries experienced a proliferation of digital health innovation that challenged
Kelley Drye & Warren LLP | USA | 22 Jan 2020
House Subcommittee Holds Hearing on Current Cannabis Policies
On January 15, the Subcommittee on Health of the Committee on Energy and Commerce held its first ever legislative hearing to address federal cannabis
Dechert LLP | USA | 21 Jan 2020
Dechert Survey: Developments in Securities Fraud Class Actions Against U.S. Life Sciences Companies
Securities class action litigation on the whole remained at a steady high in 2019, and life sciences companies were, once again, popular targets of
McDermott Will & Emery | USA | 16 Jan 2020
US Office of Management and Budget Issues a Memorandum Calling for Agency Plans From Federal Government Agencies
On January 7, 2020, the Director of the US Office of Management and Budget (OMB) issued a Draft Memorandum (the Memorandum) to all federal
McDermott Will & Emery | USA | 15 Jan 2020
Inherency Can Be Used in Obviousness Analysis to Supply Missing Limitation
Finding that inherency can be used to show the presence of a missing claim limitation, the US Court of Appeals for the Federal Circuit affirmed a
